|
DE3851002T2
(de)
|
1987-05-22 |
1995-02-02 |
University Patents, Inc., Westport, Conn. |
Lineare und zyklische Analoge von alpha-MSH-Fragmenten mit ausserordentlicher Wirkung.
|
|
US5674839A
(en)
*
|
1987-05-22 |
1997-10-07 |
Competitive Technologies, Inc. |
Cyclic analogs of alpha-MSH fragments
|
|
US5192746A
(en)
|
1990-07-09 |
1993-03-09 |
Tanabe Seiyaku Co., Ltd. |
Cyclic cell adhesion modulation compounds
|
|
US6100048A
(en)
*
|
1992-04-10 |
2000-08-08 |
Oregon Health Sciences University |
Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
|
|
JP3204510B2
(ja)
*
|
1993-04-05 |
2001-09-04 |
コンペティティブ テクノロジーズ，インク． |
勃起不全の診断および治療
|
|
US5731408A
(en)
*
|
1995-04-10 |
1998-03-24 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
|
|
US6054556A
(en)
*
|
1995-04-10 |
2000-04-25 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Melanocortin receptor antagonists and agonists
|
|
US7396814B2
(en)
*
|
1995-06-07 |
2008-07-08 |
Palatin Technologies, Inc. |
Metallopeptide compositions for treatment of sexual dysfunction
|
|
CA2158425C
(en)
|
1995-09-15 |
2003-01-28 |
Mac E. Hadley |
Diagnostic and treatment of erectile dysfunction
|
|
IL118003A0
(en)
|
1996-04-23 |
1996-08-04 |
Yeda Res & Dev |
Novel vip fragments and pharmaceutical compositions comprising them
|
|
CN1246868A
(zh)
|
1996-12-17 |
2000-03-08 |
扇形支撑剑桥有限公司 |
黑皮素
|
|
US6350430B1
(en)
*
|
1997-10-27 |
2002-02-26 |
Lion Bioscience Science Ag |
Melanocortin receptor ligands and methods of using same
|
|
US20020099003A1
(en)
*
|
1997-10-28 |
2002-07-25 |
Wilson Leland F. |
Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
|
|
GB9808229D0
(en)
|
1998-04-17 |
1998-06-17 |
Quadrant Holdings Cambridge |
Melanocortin receptor ligands
|
|
SE9801571D0
(sv)
*
|
1998-05-05 |
1998-05-05 |
Wapharm Ab |
Melanokortin-1-receptorselektiva föreningar
|
|
SE9804614A0
(en)
|
1998-07-06 |
2000-01-07 |
A+ Science Invest Ab |
New peptides and use thereof
|
|
GB9816234D0
(en)
|
1998-07-24 |
1998-09-23 |
William Harvey Research Limite |
Compounds for use in the treatment of inflammation
|
|
GB9827500D0
(en)
|
1998-12-14 |
1999-02-10 |
Wapharm Ab |
Compounds for control of eating, growth and body weight
|
|
US6887846B2
(en)
*
|
1999-03-24 |
2005-05-03 |
Zengen, Inc. |
Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
|
|
BR0009497A
(pt)
*
|
1999-03-29 |
2002-01-15 |
Procter & Gamble |
Ligantes de receptores de melanocortina
|
|
WO2003006620A2
(en)
|
2001-07-11 |
2003-01-23 |
Palatin Technologies, Inc. |
Linear and cyclic melanocortin receptor-specific peptides
|
|
US7176279B2
(en)
*
|
2000-06-28 |
2007-02-13 |
Palatin Technologies, Inc. |
Cyclic peptide compositions and methods for treatment of sexual dysfunction
|
|
US6579968B1
(en)
*
|
1999-06-29 |
2003-06-17 |
Palatin Technologies, Inc. |
Compositions and methods for treatment of sexual dysfunction
|
|
US7235625B2
(en)
*
|
1999-06-29 |
2007-06-26 |
Palatin Technologies, Inc. |
Multiple agent therapy for sexual dysfunction
|
|
US6699873B1
(en)
*
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
US20030064921A1
(en)
*
|
1999-10-27 |
2003-04-03 |
The Regents Of The University Of California |
Methods and compounds for modulating melanocortin receptor ligand binding and activity
|
|
WO2001030808A1
(en)
|
1999-10-27 |
2001-05-03 |
The Regents Of The University Of California |
Methods and compounds for modulating melanocortin receptor-ligand binding
|
|
WO2001052880A1
(en)
|
2000-01-18 |
2001-07-26 |
Merck & Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
|
|
US6600015B2
(en)
|
2000-04-04 |
2003-07-29 |
Hoffmann-La Roche Inc. |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
|
|
AU2001261363A1
(en)
|
2000-05-09 |
2001-11-20 |
The Regents Of The University Of California |
Methods and compounds for modulating melanocortin receptor ligand binding and activity
|
|
GB0012370D0
(en)
|
2000-05-22 |
2000-07-12 |
Quadrant Holdings Cambridge |
Peptoids
|
|
EP1315750B1
(en)
|
2000-08-30 |
2007-02-14 |
F. Hoffmann-La Roche Ag |
Cyclic peptides having melanocortin-4 receptor agonist activity
|
|
PL362003A1
(en)
|
2000-09-27 |
2004-10-18 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
US20030113263A1
(en)
*
|
2001-02-13 |
2003-06-19 |
Oregon Health And Sciences University, A Non-Profit Organization |
Methods and reagents for using mammalian melanocortin receptor antagonists to treat cachexia
|
|
ITMI20011057A1
(it)
|
2001-05-22 |
2002-11-22 |
Bracco Imaging Spa |
Preparazione ed uso di peptidi ciclici e ramificati e loro deriati marcati come agenti terapeutici agonisti o antagonisti della colecistochi
|
|
US7342089B2
(en)
|
2001-07-11 |
2008-03-11 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment for cachexia
|
|
US7345144B2
(en)
*
|
2001-07-11 |
2008-03-18 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment of cachexia
|
|
EP1409521A2
(en)
|
2001-07-12 |
2004-04-21 |
Merck & Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor agonists
|
|
JP2005527492A
(ja)
*
|
2002-01-23 |
2005-09-15 |
イーライ・リリー・アンド・カンパニー |
メラノコルチン受容体アゴニスト
|
|
FR2835528B1
(fr)
*
|
2002-02-01 |
2004-03-12 |
Inst Europ Biolog Cellulaire |
Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique
|
|
US7034004B2
(en)
*
|
2002-05-07 |
2006-04-25 |
University Of Florida |
Peptides and methods for the control of obesity
|
|
WO2004005324A2
(en)
|
2002-07-09 |
2004-01-15 |
Palatin Technologies, Inc. |
Peptide composition for treatment of sexual dysfunction
|
|
US7135548B2
(en)
*
|
2002-11-14 |
2006-11-14 |
Zengen, Inc. |
Modified α-MSH peptides and derivatives thereof
|
|
US20060122121A1
(en)
|
2002-11-14 |
2006-06-08 |
Lipton James M |
Modified alpha-MSH peptides and derivatives thereof
|
|
US20050101535A1
(en)
*
|
2003-05-06 |
2005-05-12 |
Rosenstein David H. |
Use of a synthetic alpha-melanocyte stimulating hormone agonist to decrease steroid induced weight gain
|
|
JP2007524584A
(ja)
|
2003-05-09 |
2007-08-30 |
ノボ ノルディスク アクティーゼルスカブ |
肥満の治療に使用するペプチド
|
|
MXPA05011830A
(es)
*
|
2003-05-09 |
2006-01-26 |
Novo Nordisk As |
Peptidos para uso en el tratamiento de la obesidad.
|
|
CA2530024A1
(en)
*
|
2003-06-19 |
2005-01-06 |
Eli Lilly And Company |
Melanocortin receptor 4(mc4) agonists and their uses
|
|
JP2006527772A
(ja)
|
2003-06-19 |
2006-12-07 |
イーライ リリー アンド カンパニー |
メラノコルチン３受容体（ｍｃ３ｒ）作用薬ペプチドの用途
|
|
US7084111B2
(en)
|
2003-06-23 |
2006-08-01 |
University Of Florida Research Foundation, Inc. |
Melanocortin receptor templates, peptides, and use thereof
|
|
WO2005019212A1
(en)
*
|
2003-08-20 |
2005-03-03 |
Eli Lilly And Company |
Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
|
|
KR20060089874A
(ko)
*
|
2003-09-30 |
2006-08-09 |
노보 노르디스크 에이/에스 |
신규 멜라노코르틴 수용체 작용제
|
|
DK1689349T3
(da)
|
2003-11-24 |
2013-12-02 |
Clinuvel Pharmaceuticals Ltd |
Fremgangsmåde til induktion af melanogenese i mennesker med variante MC1R-alleler
|
|
WO2005060985A1
(en)
|
2003-12-10 |
2005-07-07 |
Merck & Co., Inc. |
Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
|
|
EP1732586A1
(en)
|
2004-03-29 |
2006-12-20 |
Eli Lilly And Company |
Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continunous infusion
|
|
CN1563076A
(zh)
|
2004-04-02 |
2005-01-12 |
西南生物工程产业化中试基地有限公司 |
一种用于治疗性功能障碍的α－MSH类似物及制备方法
|
|
DK1789076T3
(en)
|
2004-08-04 |
2016-04-11 |
Clinuvel Pharmaceuticals Ltd |
METHODS for inducing melanogenesis in a subject
|
|
TW200626611A
(en)
|
2004-09-20 |
2006-08-01 |
Lonza Ag |
Peptide cyclisation
|
|
EP1812034A4
(en)
|
2004-10-08 |
2009-07-29 |
Clinuvel Pharmaceuticals Ltd |
COMPOSITIONS AND METHODS OF INDUCING MELANOESEES IN ONE PERSON
|
|
KR101255140B1
(ko)
*
|
2004-10-25 |
2013-04-22 |
얀센 바이오테크 인코포레이티드 |
멜라노코르틴 수용체 결합 모방체, 조성물, 방법 및 용도
|
|
JP2008519009A
(ja)
|
2004-11-04 |
2008-06-05 |
ノボ ノルディスク アクティーゼルスカブ |
肥満症の治療に使用するためのペプチド
|
|
US20110098213A1
(en)
|
2004-11-04 |
2011-04-28 |
Novo Nordisk A/S |
Novel peptides for use in the treatment of obesity
|
|
CN101052649A
(zh)
|
2004-11-04 |
2007-10-10 |
诺和诺德公司 |
用于治疗肥胖的肽类
|
|
WO2006048449A2
(en)
|
2004-11-04 |
2006-05-11 |
Novo Nordisk A/S |
Mc4r selective peptides and their use in the treatment of obesity
|
|
WO2006060873A1
(en)
|
2004-12-09 |
2006-06-15 |
Prince Henry's Institute Of Medical Research |
Method for restoring reproductive function
|
|
WO2006073771A2
(en)
|
2005-01-05 |
2006-07-13 |
Eli Lilly And Company |
Polyethylene glycol linked mc4r or mc3r agonist peptides
|
|
WO2006076442A2
(en)
|
2005-01-14 |
2006-07-20 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives
|
|
US20080207493A1
(en)
|
2005-03-17 |
2008-08-28 |
Novo Nordisk A/S |
Compounds for Use in the Treatment of Obesity
|
|
EP1885743A1
(en)
|
2005-05-31 |
2008-02-13 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
BACKBONE CYCLIZED MELANOCORTIN STIMULATING HORMONE ( alpha S ) ANALOGS
|
|
EP2236151B1
(en)
|
2005-07-08 |
2012-05-23 |
Ipsen Pharma |
Melanocortin receptor ligands
|
|
WO2007008684A2
(en)
|
2005-07-08 |
2007-01-18 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. |
Ligands of melanocortin receptors
|
|
CN1709906A
(zh)
|
2005-07-15 |
2005-12-21 |
中国科学技术大学 |
α－促黑激素的环状类似肽及其应用
|
|
WO2007009894A2
(en)
|
2005-07-18 |
2007-01-25 |
Novo Nordisk A/S |
Peptides for use in the treatment of obesity
|
|
EP1957096A4
(en)
|
2005-08-29 |
2012-03-21 |
Palatin Technologies Inc |
CYCLIC PEPTIDE INSULATION BY SPRAY DRYING
|
|
WO2007035474A2
(en)
|
2005-09-15 |
2007-03-29 |
Novomed Technologies, Inc. (Shanghai) |
Transdermal delivery peptides and method of use thereof
|
|
AU2006350707A1
(en)
|
2006-11-08 |
2008-05-15 |
Chongxi Yu |
Transdermal delivery systems of peptides and related compounds
|
|
JP2010517943A
(ja)
|
2007-01-18 |
2010-05-27 |
ノボ・ノルデイスク・エー／エス |
肥満の治療に使用される新規ペプチド
|
|
US20100016237A1
(en)
|
2007-01-18 |
2010-01-21 |
Novo Nordisk A/S |
Novel Peptides for Use in the Treatment of Obesity
|
|
EP2106406A2
(en)
|
2007-01-18 |
2009-10-07 |
Novo Nordisk A/S |
Novel peptides for use in the treatment of obesity
|
|
EP2101822A2
(en)
|
2007-01-18 |
2009-09-23 |
Novo Nordisk A/S |
Use of peptides in combination with surgical intervention for the treatment of obesity
|
|
WO2008087189A2
(en)
|
2007-01-18 |
2008-07-24 |
Novo Nordisk A/S |
Peptides for use in the treatment of obesity
|
|
FR2914646A1
(fr)
|
2007-04-04 |
2008-10-10 |
Neorphys Soc Par Actions Simpl |
Analogues peptidiques des recepteurs des melanocortines
|
|
WO2008156677A2
(en)
|
2007-06-15 |
2008-12-24 |
Ipsen Pharma S.A.S. |
Cyclic peptide melanocortin receptor ligands
|
|
AR072072A1
(es)
*
|
2008-06-09 |
2010-08-04 |
Palatin Technologies Inc |
Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669
|
|
CA2727317C
(en)
|
2008-06-09 |
2015-02-17 |
Palatin Technologies, Inc. |
Melanocortin receptor-specific peptides for treatment of sexual dysfunction
|
|
UY32690A
(es)
*
|
2009-06-08 |
2011-01-31 |
Astrazeneca Ab |
Péptidos específicos para receptores de melanocortina
|
|
EP2440572B1
(en)
|
2009-06-08 |
2017-04-05 |
Palatin Technologies, Inc. |
Lactam-bridged melanocortin receptor-specific peptides
|